| Natriuretic peptide–based screening and collaborative care for heart failure: the STOP-HF randomized trial M Ledwidge, J Gallagher, C Conlon, E Tallon, E O’Connell, I Dawkins, ... Jama 310 (1), 66-74, 2013 | 641 | 2013 |
| Agreement between activPAL and ActiGraph for assessing children's sedentary time ND Ridgers, J Salmon, K Ridley, E O'Connell, L Arundell, A Timperio International Journal of Behavioral Nutrition and Physical Activity 9, 1-8, 2012 | 252 | 2012 |
| MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure CJ Watson, SK Gupta, E O'Connell, S Thum, N Glezeva, J Fendrich, ... European journal of heart failure 17 (4), 405-415, 2015 | 229 | 2015 |
| Assessing volume of accelerometry data for reliability in preschool children. T Hinkley, E O'Connell, AD Okely, D Crawford, K Hesketh, J Salmon Medicine and science in sports and exercise 44 (12), 2436-2441, 2012 | 113 | 2012 |
| Cost‐effectiveness of natriuretic peptide‐based screening and collaborative care: a report from the STOP‐HF (St Vincent's Screening TO Prevent Heart Failure) study MT Ledwidge, E O'Connell, J Gallagher, L Tilson, S James, V Voon, ... European journal of heart failure 17 (7), 672-679, 2015 | 51 | 2015 |
| Sacubitril‐Valsartan in a routine community population: attention to volume status critical to achieving target dose RB Pharithi, M Ferre‐Vallverdu, AS Maisel, E O'Connell, M Walshe, ... ESC heart failure 7 (1), 159-167, 2020 | 34 | 2020 |
| Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up G Murtagh, T Lyons, E O’Connell, J Ballot, L Geraghty, D Fennelly, ... Breast cancer research and treatment 156, 501-506, 2016 | 33 | 2016 |
| Life expectancy for community-based patients with heart failure from time of diagnosis S James, D Barton, E O'Connell, V Voon, G Murtagh, C Watson, T Murphy, ... International journal of cardiology 178, 268-274, 2015 | 32 | 2015 |
| A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program TM Murphy, DF Waterhouse, S James, C Casey, E Fitzgerald, E O'Connell, ... International Journal of Cardiology 232, 330-335, 2017 | 30 | 2017 |
| Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population? M Bermingham, MK Shanahan, E O’Connell, I Dawkins, S Miwa, ... Circulation: Heart Failure 7 (2), 243-250, 2014 | 28 | 2014 |
| Biomarker profiling for risk of future heart failure (HFpEF) development CJ Watson, J Gallagher, M Wilkinson, A Russell-Hallinan, I Tea, S James, ... Journal of Translational Medicine 19, 1-10, 2021 | 26 | 2021 |
| Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis K McDonald, N Glezeva, P Collier, J O’Reilly, E O’Connell, I Tea, ... Scientific Reports 10 (1), 7507, 2020 | 22 | 2020 |
| Socio-demographic characteristics of children experiencing socioeconomic disadvantage who meet physical activity and screen-time recommendations: the READI study C Hume, J Salmon, J Veitch, E O'Connell, D Crawford, K Ball Preventive Medicine 54 (1), 61-64, 2012 | 21 | 2012 |
| Standardising the ‘after-school’period for children’s physical activity and sedentary behaviour L Arundell, J Salmon, J Veitch, E O’Connell, T Hinkley, C Hume Health Promotion Journal of Australia 24 (1), 65-67, 2013 | 18 | 2013 |
| BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF) A Beshiri, G Murtagh, C Watson, E O'connell, J O'reilly, S James, ... US Patent App. 15/625,510, 2017 | 10 | 2017 |
| Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure C Watson, S James, E O’Connell, J Gallagher, J O’Reilly, E Tallon, ... Biomarkers 21 (6), 538-543, 2016 | 7 | 2016 |
| Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community CJ Watson, I Tea, E O'Connell, N Glezeva, S Zhou, S James, J Gallagher, ... Journal of Cellular and Molecular Medicine 24 (11), 6495-6499, 2020 | 6 | 2020 |
| 22 Role of 12-lead electrocardiography in predicting heart failure in the community S James, T Murphy, DF Waterhouse, J Gallagher, E O’Connell, D Barton, ... Heart 101 (Suppl 5), A12-A12, 2015 | 4 | 2015 |
| New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure S McClelland, S Zhou, E O'Connell, J Gallagher, F Ryan, CJ Watson, ... European journal of heart failure 22 (2), 378-380, 2020 | 2 | 2020 |
| Silent risk? Cardiovascular risk factor control and stage B heart failure in survivors of breast cancer treated with anthracyclines G Murtagh, T Lyons, L Geraghty, J Ballot, E O'connell, M Ledwidge, ... European Journal of Heart Failure 12, S289-S289, 2013 | 2 | 2013 |
